NAD Recommends Similac Discontinue “#1 Pediatrician Recommended Brands” Claim in Resolved Fast-Track SWIFT Case

For Immediate Release 
Contact: Abby Hills, Director of Communications, BBB National Programs 

703.247.9330 / press@bbbnp.org  

New York, NY – October 2, 2020 – The National Advertising Division (NAD) of BBB National Programs, in a Fast-Track SWIFT challenge brought by Mead Johnson & Company, recommended that Abbott Nutrition discontinue the claim “#1 Pediatrician Recommended Brands” due to a lack of a clear and understandable disclosure. The challenged claim appeared in online and social media advertising for Similac branded cow’s milk formulas, and the advertiser intended to include it on Similac product labels. 

NAD Fast-Track SWIFT is an expedited process designed for single-issue digital advertising cases. This case was appropriate for the NAD Fast-Track SWIFT process because the issue was limited to whether the advertiser’s substantiation was a good fit for the challenged claim.  

NAD determined that as currently presented, the disclosure “based on combined recommendations of Similac and EleCare” does not, in a clear and understandable manner, disclose that the basis for the advertiser’s “#1 Pediatrician Recommended Brands” claim is based on combining pediatrician recommendations for the various traditional infant formulas (Enfamil, Gerber Good Start, Parent’s Choice, and Similac) with pediatrician recommendations for amino acid formulas (Alfamino, EleCare, Neocate, and PurAmino).  

Therefore, NAD concluded that the claim was not a good fit for the evidence presented and recommended that it be discontinued. 

NAD is now accepting three types of claims for consideration in the streamlined SWIFT process: 

  • The prominence and sufficiency of disclosures in influencer marketing and native advertising; 
  • Misleading pricing and sales claims; and
  • Misleading express claims that do not require review of complex evidence or substantiation. 


Two additional Fast-Track SWIFT challenges were filed in August but were transferred to Standard Track. The decisions in those cases, when released, will indicate that the challenge was originally brought in Fast-Track SWIFT.

Learn more about the NAD Fast-Track SWIFT challenge process and how to file a challenge. 

### 

About BBB National Programs: BBB National Programs is where businesses turn to enhance consumer trust and consumers are heard. The non-profit organization creates a fairer playing field for businesses and a better experience for consumers through the development and delivery of effective third-party accountability and dispute resolution programs. Embracing its role as an independent organization since the restructuring of the Council of Better Business Bureaus in June 2019, BBB National Programs today oversees more than a dozen leading national industry self-regulation programs, and continues to evolve its work and grow its impact by providing business guidance and fostering best practices in arenas such as advertising, child-directed marketing, and privacy. To learn more, visit bbbprograms.org. 

About the National Advertising Division: The National Advertising Division (NAD), a division of BBB National Programs, provides independent self-regulation and dispute resolution services, guiding the truthfulness of advertising across the U.S. NAD reviews national advertising in all media and its decisions set consistent standards for advertising truth and accuracy, delivering meaningful protection to consumers and leveling the playing field for business.     

Latest Decisions

Decision

IV Drip Voluntarily Discontinues Social Media Posts for IV Hydration Therapy Following NAD Inquiry into Implied COVID-19 Messages

New York, NY – October 28, 2020 – Following an inquiry by the National Advertising Division (NAD), IV Drips Customized IV Hydration & Wellness (“IV Drips”) discontinued Instagram and Facebook social media posts which conveyed implied messages that its IV Hydration Therapy protects...

Read Decision
Decision

NAD Finds Certain doTERRA Phrases to be Puffery; Recommends Discontinuation of Challenged Essential Oils Health Benefit Claims; Advertiser to Appeal

New York, NY – October 27, 2020 – The National Advertising Division (NAD) determined that doTERRA International, LLC (doTERRA) did not provide a reasonable basis for claims that its doTERRA essential oils provide certain health benefits, including specific benefits for mood,...

Read Decision
Decision

NAD Finds France Media’s Readership Claims Supported; Recommends Modification of “Largest Commercial Real Estate Publisher” Claim

New York, NY – October 22, 2020 – The National Advertising Division (NAD) determined that France Media Inc. (FMI) provided a reasonable basis for certain readership claims for its Commercial Real Estate Publishing Platform, but recommended that FMI modify its claims that it is the “largest...

Read Decision
Decision

NARB Recommends Benefiber Discontinue “100% Natural” and “Clinically Proven” Claims, But Finds “Helps You Feel Fuller Longer” Claim Supported

New York, NY – October 22, 2020 – The National Advertising Review Board (NARB) recommended that GlaxoSmithKline Consumer Healthcare, LLC (GSK) discontinue “100% natural” and “clinically proven to curb cravings” claims for Benefiber, and determined that GSK...

Read Decision